tiprankstipranks
UMP Healthcare Holdings Limited (HK:0722)
:0722
Hong Kong Market

UMP Healthcare Holdings Limited (0722) AI Stock Analysis

Compare
3 Followers

Top Page

HK:0722

UMP Healthcare Holdings Limited

(0722)

Select Model
Select Model
Select Model
Rating:74Outperform
Price Target:
HK$0.50
â–²(4.17% Upside)
Action:N/ADate:07/19/25
UMP Healthcare's overall stock score of 74 is driven primarily by strong technical momentum, with the stock trading above key moving averages and showing bullish indicators. Financial performance is solid, supported by a stable balance sheet and cash flow growth, though declining profitability margins are a concern. Valuation is reasonable with an attractive dividend yield. The score reflects a positive outlook with financial stability, tempered by profitability challenges.
Positive Factors
Governance Enhancement
Improved governance structure with diverse board and committees strengthens decision-making and stakeholder trust, positively impacting long-term strategy.
Negative Factors
Debt-to-Equity Increase
An increase in debt-to-equity ratio, although slight, could signal rising leverage, which may constrain financial flexibility if not managed prudently.
Read all positive and negative factors
Positive Factors
Negative Factors
Governance Enhancement
Improved governance structure with diverse board and committees strengthens decision-making and stakeholder trust, positively impacting long-term strategy.
Read all positive factors

UMP Healthcare Holdings Limited (0722) vs. iShares MSCI Hong Kong ETF (EWH)

UMP Healthcare Holdings Limited Business Overview & Revenue Model

Company Description
UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in two segments, Corporate Healthcare Solution Services and Clinical Healthcar...
How the Company Makes Money
UMP Healthcare makes money primarily through its extensive network of medical centers and clinics, which provide various healthcare services to patients. The company generates revenue through patient consultations, medical examinations, and specia...

UMP Healthcare Holdings Limited Financial Statement Overview

Summary
UMP Healthcare shows a balanced financial profile with a stable balance sheet (score: 75) due to low leverage and a strong equity ratio, solid cash flow (score: 70) with notable free cash flow growth, and moderate income statement performance (score: 65) impacted by declining profitability margins despite revenue growth. The score reflects resilience with room for improvement in profitability.
Income Statement
65
Positive
Balance Sheet
75
Positive
Cash Flow
70
Positive
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue727.36M748.49M727.75M666.20M617.16M
Gross Profit490.61M692.25M502.69M463.95M456.28M
EBITDA80.24M161.98M178.21M170.15M170.44M
Net Income31.44M40.64M60.45M72.17M34.83M
Balance Sheet
Total Assets1.10B1.11B1.12B1.04B969.98M
Cash, Cash Equivalents and Short-Term Investments341.70M307.49M318.58M291.65M344.59M
Total Debt161.55M172.57M172.22M148.34M78.03M
Total Liabilities343.53M362.14M351.54M300.30M276.92M
Stockholders Equity742.63M725.94M740.55M698.65M639.50M
Cash Flow
Free Cash Flow0.0091.54M80.71M26.40M149.17M
Operating Cash Flow0.00148.78M190.04M110.91M172.67M
Investing Cash Flow0.00-68.49M-134.09M-77.12M-39.26M
Financing Cash Flow0.00-117.13M-53.67M-90.98M-69.21M

UMP Healthcare Holdings Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.48
Price Trends
50DMA
0.46
Positive
100DMA
0.45
Positive
200DMA
0.45
Positive
Market Momentum
MACD
<0.01
Positive
RSI
47.61
Neutral
STOCH
24.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0722, the sentiment is Neutral. The current price of 0.48 is above the 20-day moving average (MA) of 0.47, above the 50-day MA of 0.46, and above the 200-day MA of 0.45, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 47.61 is Neutral, neither overbought nor oversold. The STOCH value of 24.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0722.

UMP Healthcare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$368.44M4.984.28%7.10%-2.88%-22.83%
71
Outperform
HK$712.26M3.305.29%9.14%0.47%50.46%
64
Neutral
HK$173.06M5.316.92%8.00%-21.50%-43.25%
55
Neutral
HK$450.00M4.085.27%4.49%20.85%-66.81%
54
Neutral
HK$263.57M-1.35-8.34%3.16%-21.31%-149.92%
52
Neutral
HK$315.03M4.113.54%3.75%9.07%8.95%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0722
UMP Healthcare Holdings Limited
0.46
0.07
17.65%
HK:1419
Human Health Holdings Ltd.
0.83
0.00
0.00%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.54
-0.64
-54.24%
HK:2189
Kato (Hong Kong) Holdings Ltd.
0.45
0.00
0.00%
HK:2293
Bamboos Health Care Holdings Ltd
0.43
-0.11
-20.37%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.02
0.19
10.38%

UMP Healthcare Holdings Limited Corporate Events

UMP Healthcare’s AGM Resolutions Passed Unanimously
Nov 21, 2025
UMP Healthcare Holdings Limited announced the successful passing of all proposed resolutions during its Annual General Meeting held on November 21, 2025. Key resolutions included the adoption of financial statements, declaration of a final dividen...
UMP Healthcare Approves New Medical Services Agreement with CTF Life
Nov 21, 2025
UMP Healthcare Holdings Limited announced the results of its extraordinary general meeting held on November 21, 2025, where a resolution to approve a medical services agreement with CTF Life was passed unanimously. The agreement is expected to str...
UMP Healthcare Announces Board and Leadership Changes
Nov 21, 2025
UMP Healthcare Holdings Limited announced significant changes in its board composition following the conclusion of its annual general meeting on November 21, 2025. Dr. LI Kwok Tung, Donald and Dr. LEE Kar Chung, Felix have both concluded their ten...
UMP Healthcare Announces Board and Committee Composition
Nov 21, 2025
UMP Healthcare Holdings Limited has announced the composition of its board of directors and the members of its key committees, including the Audit, Remuneration, and Nomination Committees. This announcement highlights the leadership structure of t...
UMP Healthcare to Discuss New Medical Services Agreement at Upcoming EGM
Nov 5, 2025
UMP Healthcare Holdings Limited has announced an extraordinary general meeting scheduled for November 21, 2025, to discuss and potentially approve the 2026 CTF Life Medical Services Agreement. This agreement, involving UMP Professional and CTF Lif...
UMP Healthcare Announces Book Closure for Upcoming EGM
Nov 4, 2025
UMP Healthcare Holdings Limited has announced the book closure period for its upcoming Extraordinary General Meeting (EGM) scheduled for November 21, 2025. This meeting will address continuing connected transactions related to the 2026 CTF Life Me...
UMP Healthcare Announces AGM and Share Repurchase Mandate
Oct 27, 2025
UMP Healthcare Holdings Limited has announced its upcoming annual general meeting scheduled for November 21, 2025, where key agenda items include the adoption of financial statements, declaration of a final dividend, and re-election of directors. ...
UMP Healthcare Expands Medical Services Through New Agreement
Oct 14, 2025
UMP Healthcare Holdings Limited announced a supplemental agreement regarding continuing connected transactions related to medical services. The agreement with Pedder Healthcare Group aims to enhance UMP&#8217;s service offerings by integrating spe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 19, 2025